MedPath

A Study to compare the effect of three drugs -Dexmedetomidine, Lidocaine and Fentanyl in increasing heart rate and blood pressure in response to Laryngoscopy and Intubation in patients undergoing Cardiac Surgery

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/05/042885
Lead Sponsor
Department of Anaesthesiology
Brief Summary

Laryngoscopy and endotracheal intubation are associated with various hemodynamic changes due to sympathetic stimulation and to attenuate these responses is a major challenge for the anaesthesiologist. Hence, this study is designed to compare effects of intravenous Dexmedetomidine, Lidocaine and Fentanyl in Attenuation of Hemodynamic Response of Laryngoscopy and Intubation in patients undergoing Cardiac surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

1.Informed Consent 2.Patients undergoing Elective Cardiac Surgery 3.Ejection Fraction >35% 4.ASA Grade 2 and 3 5.BMI<30.

Exclusion Criteria

1.Intubation Attempt lasting longer than 15s and any intubation related problem 2.Allergic Sensitivity to the research medications 3.Patients with hypotension(SBP<90 mmhg) 4.Bradycardia(HR<60/min) 5.Diabetes 6.Asthma 7.Pregnancy 8.Chronic Kidney and liver diseases 9.Long QT 10.Any Addiction.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart Rate, Systolic Blood Pressure, Diastolic Blood Pressure, Mean Arterial PressureBefore Intubation and 1,3,5,10 and 15 minutes post intubation
Secondary Outcome Measures
NameTimeMethod
Percentage of cases who experience side effects or complications(if any)24 hours postoperation

Trial Locations

Locations (1)

S.M.S Medical College Hospital

🇮🇳

Jaipur, RAJASTHAN, India

S.M.S Medical College Hospital
🇮🇳Jaipur, RAJASTHAN, India
Dr Indu Verma
Principal investigator
9413622967
dr.induverma@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.